-
08.05.2024 Consolidated Financial Results for the First Quarter of Fiscal 2024
（292KB）
読む Consolidated Financial Results for the First Quarter of Fiscal 2024
-
05.23.2024 Convocation Notice of the 78th Ordinary General Meeting of Shareholders
（174KB）
読む Convocation Notice of the 78th Ordinary General Meeting of Shareholders
-
05.14.2024 Seikagaku Announces the Biologics License Application for SI-6603 Has Been Accepted for Filing by the U.S. FDA
（141KB）
-
05.13.2024 Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
（384KB）
読む Consolidated Financial Results for the Fiscal Year Ended March 31, 2024
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
-
08.05.2024 Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2025
-
07.29.2024 Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2025 at 15:30 on August 5, 2024
-
06.21.2024 New Message from President & CEO
-
05.16.2024 Presentation Material for the Briefing on FY2023 Financial Results
読む Presentation Material for the Briefing on FY2023 Financial Results
